Acknowledging the kind of traction gained by this market, Industry Data Analytics recently published a study report asserts the global Influenza Diagnostics Market size is projected to accrue voluminously by 2027 registering a phenomenal CAGR of 7.2% during the review period (2022 to 2027).
Influenza Diagnostics Market Overview
The growing prevalence of influenza creating the need to deliver effective treatment can favor the expansion of the influenza diagnostic market. In addition, a rise in funding for research in influenza diagnosis can add to the market expansion. The fast-growing demand for quick diagnostic solutions can favor market expansion in the years to come. The increase in awareness about such disease and the introduction of quadrivalent influenza vaccines can drive the influenza diagnostics market in the coming years. Increasing awareness among the global population regarding the importance of early disease detection is a major factor responsible for the growth of the global market for influenza diagnostics. Owing to this, organizations are taking initiatives to promote early diagnosis practice to prevent and eradicate mortality due to the disease.
Who are the Major Players in Influenza Diagnostics Market?
Top Key players in the Influenza Diagnostics Market have been identified through secondary research, and their market shares have been determined through primary and secondary research. The global Influenza Diagnostics Market is fragmented with a large number of small players operating worldwide. The companies referred in the market research report includes BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel Corporation (NasdaqGS:QDEL), Thermo Fisher Scientific Inc. (NYSE:TMO), Meridian Bioscience , Inc. (NasdaqGS:VIVO), BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, Enigma Diagnostics, Focus Diagnostics and others.
Industry News:
January 2021- Korean researchers developed new SERS-based sensor that can detect high reproducible, influenza A viral pathogens.
January 2021-Labs that are performing Flu SC2 Multiplex Assay recognized by the Centers for Disease Control’s (CDC), which is a single test to diagnose infection caused due to influenza A, SARS-CoV-2, or influenza B, can now use a Promega nucleic acid purification kit and two Promega instruments. Promega is a Wisconsin-based producer of enzymes and other types of molecular biology and biotechnology portfolio
What are the major Applications, Types and Regions for Influenza Diagnostics Market?
Influenza Diagnostics Market is segmented based on the type, applications, companies and regions.
By Type, Influenza Diagnostics Market has been segmented into
The end user’s industry application on Influenza Diagnostics Market are,
Influenza Diagnostics Market Regional Analysis:
In Europe, the aviation test equipment market can secure the second-largest share of the global market. The rise in count of pharmaceutical companies dealing in exporting their products is also responsible for growth of the regional market. Rise in disease awareness, and extended recommendations by advisory bodies and governmental for vaccination against influenza can contribute to the market upsurge. North America and Europe currently hold more than 60% of the global influenza diagnostics market. The high prevalence of respiratory disease such as seasonal flu are propelling the demand for influenza diagnostics test in North America.
However, East Asia and South Asia are poised for significant growth over the forecast period owing to factors such as large population base, increase burden of infectious disease, and wide use of rapid influenza diagnostic tests.
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Middle East & Africa
- Latin America
What is our Influenza Diagnostics Market report scope?
Report Attributes
|
Report Details
|
Forecast Period 2022 to 2027 CAGR
|
CAGR of 7.2% during the review period (2022 to 2027).
|
By Type
|
|
By Application
|
|
By Companies
|
BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel Corporation (NasdaqGS:QDEL), Thermo Fisher Scientific Inc. (NYSE:TMO), Meridian Bioscience , Inc. (NasdaqGS:VIVO), BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, Enigma Diagnostics, Focus Diagnostics and others.
|
Regions Covered
|
- North America
- Europe
- Asia-Pacific
- Rest of the World
|
Countries Covered
|
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Latin America
|
Base Year
|
2022
|
Historical Year
|
2017 to 2021
|
Forecast Year
|
2022 to 2027
|
Number of Pages
|
122
|
Customization Available
|
Yes, the report can be customized as per your needs
|
Key Takeaways from this Influenza Diagnostics Report
- Evaluate Influenza Diagnostics market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.
- Understand the different dynamics influencing the market - key driving factors, challenges and hidden opportunities.
- Get in-depth insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
- Analyze the sales and distribution channels across key geographies to improve top-line revenues.
- Understand the industry supply chain with a deep dive on the value augmentation at each step, in order to optimize value and bring efficiencies in your processes.
- Get a quick outlook on the Influenza Diagnostics market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.
- Evaluate the supply-demand gaps, import-export statistics and regulatory landscape for more than top 20 countries globally for the market.
Frequently Asked Questions
What is the study period of this market?
The Influenza Diagnostics Market is studied from 2017 - 2027.
What is the growth rate of Influenza Diagnostics Market?
The Influenza Diagnostics Market is growing at a CAGR of 7.2% over the next 5 years.
Who are the leading key players in Influenza Diagnostics Market?
BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel Corporation (NasdaqGS:QDEL), Thermo Fisher Scientific Inc. (NYSE:TMO), Meridian Bioscience , Inc. (NasdaqGS:VIVO), BioMerieux, Sekisui Diagnostics, Response Biomedical, SA Scientific, Enigma Diagnostics, Focus Diagnostics and others.
What regions regions does this Influenza Diagnostics Market report covers?
North America (the United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, and Italy)
Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
What are the significant types of Influenza Diagnostics Market?
RIDT, RT-PCR, Cell Culture
What are the significant Applications of Influenza Diagnostics Market?
Hospitals, POCT, Others
All our reports are customizable to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report to your needs.
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.